{"transactions":[{"id":680328,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-20T20:20:52.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":664,"price":514.97,"value":341940.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":11474,"source":{"system":"sec-edgar","filing":"0001628280-26-058256","document":"wk-form4_1787257250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026058256/wk-form4_1787257250.xml","form_type":"4"}},{"id":856467,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T23:34:05.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":5022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":5022,"derivative":{"exercise_price":434.8,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":5022},"source":{"system":"sec-edgar","filing":"0001628280-26-015763","document":"wk-form4_1772840042.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015763/wk-form4_1772840042.xml","form_type":"4"}},{"id":856466,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-03-06T23:34:05.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":360,"price":431.94,"value":155498.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":12138,"source":{"system":"sec-edgar","filing":"0001628280-26-015763","document":"wk-form4_1772840042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015763/wk-form4_1772840042.xml","form_type":"4"}},{"id":856465,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-03-06T23:34:05.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":4017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":12498,"source":{"system":"sec-edgar","filing":"0001628280-26-015763","document":"wk-form4_1772840042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026015763/wk-form4_1772840042.xml","form_type":"4"}},{"id":935671,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-20T22:58:20.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":429,"price":501.4,"value":215100.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."}],"balance_after":8481,"source":{"system":"sec-edgar","filing":"0001628280-26-002742","document":"wk-form4_1768949897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026002742/wk-form4_1768949897.xml","form_type":"4"}},{"id":935670,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-20T22:58:20.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":263,"price":490.77,"value":129072.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":8910,"source":{"system":"sec-edgar","filing":"0001628280-26-002742","document":"wk-form4_1768949897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828026002742/wk-form4_1768949897.xml","form_type":"4"}},{"id":1064314,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":42,"price":376.62,"value":15818.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.60 to $376.64, inclusive."}],"balance_after":9173,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064313,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":190,"price":375.7536,"value":71393.184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.46 to $376.06, inclusive."}],"balance_after":9215,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064312,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":68,"price":374.1344,"value":25441.1392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.77 to $374.36, inclusive."}],"balance_after":9405,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064311,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":252,"price":372.44,"value":93854.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.25 to $372.76, inclusive."}],"balance_after":9473,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064310,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":84,"price":371.35,"value":31193.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.22 to $371.48, inclusive."}],"balance_after":9725,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064309,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":84,"price":370.06,"value":31085.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."}],"balance_after":9809,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064308,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":126,"price":369.642,"value":46574.892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $369.02 to $369.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":9893,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1064307,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-08-18T21:33:51.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":458,"price":358.66,"value":164266.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":10019,"source":{"system":"sec-edgar","filing":"0002034056-25-000009","document":"wk-form4_1755552828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000203405625000009/wk-form4_1755552828.xml","form_type":"4"}},{"id":1217902,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T21:50:46.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":5368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (March 5, 2026) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":5368,"derivative":{"exercise_price":347.28,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":5368},"source":{"system":"sec-edgar","filing":"0001628280-25-011354","document":"wk-form4_1741384239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025011354/wk-form4_1741384239.xml","form_type":"4"}},{"id":1217901,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-03-07T21:50:46.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":3187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":10477,"source":{"system":"sec-edgar","filing":"0001628280-25-011354","document":"wk-form4_1741384239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025011354/wk-form4_1741384239.xml","form_type":"4"}},{"id":1223442,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-03-05T21:36:22.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":415,"price":335,"value":139025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024."}],"balance_after":7290,"source":{"system":"sec-edgar","filing":"0001628280-25-010510","document":"wk-form4_1741210575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025010510/wk-form4_1741210575.xml","form_type":"4"}},{"id":1300454,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-01-18T00:10:30.000Z","date":"2025-01-17","kind":"sale","planned":false,"acquired":false,"shares":277,"price":273.41,"value":75734.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person."}],"balance_after":7705,"source":{"system":"sec-edgar","filing":"0001628280-25-001902","document":"wk-form4_1737159023.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000162828025001902/wk-form4_1737159023.xml","form_type":"4"}},{"id":1429757,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-20T00:16:25.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":7820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on the first anniversary of the date of grant (August 15, 2025) and, thereafter, 6.25% of the shares shall vest on each quarterly anniversary following the first anniversary, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":7820,"derivative":{"exercise_price":244.5,"expiration_date":"2034-08-15","underlying":"Common Stock","underlying_shares":7820},"source":{"system":"sec-edgar","filing":"0000950170-24-098804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024098804/ownership.xml","form_type":"4"}},{"id":1429756,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":21325,"kind":"person","name":"Kelley Shannon T","position":1,"cik":"0002034056","reported_name":"Kelley Shannon T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-08-20T00:16:25.000Z","date":"2024-08-15","kind":"grant","planned":false,"acquired":true,"shares":5215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, which vest as to 25% of the shares on each of August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date."}],"balance_after":7982,"source":{"system":"sec-edgar","filing":"0000950170-24-098804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000095017024098804/ownership.xml","form_type":"4"}}]}